Open Biosystems to Sell Codon's Synthetic Genetics Tech in N. America | GenomeWeb
NEW YORK (GenomeWeb News) — Open Biosystems will sell and distribute Codon Devices’ BioFAB synthetic genetics platform in North America, Codon said Monday.  
Codon said the agreement is part of its effort to extend its BioFAB platform to a broader market. Previously, Codon offered BioFAB only to customers able to meet minimum order requirements.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.